Skip to main content
. 2013 Nov 20;8(11):e79492. doi: 10.1371/journal.pone.0079492

Table 1. Sociodemographic Characteristics, Sexual Behavior Characteristics, HIV, and Human papillomavirus (HPV) infection Characteristics of 1262 Multicenter AIDS Cohort Study Participants Evaluated for HPV DNA using Anal Swab Specimens.

HIV Seropositive HIV Seronegative Total
(N = 579) (N = 683) (N = 1262)
n (%) n (%) n (%)
Characteristic
Age (years)
<30 4 (01) 9 (01) 13 (01)
30–39 31 (05) 34 (05) 65 (05)
40–49 154 (27) 108 (16) 262 (21)
50–59 280 (48) 277 (41) 557 (44)
60–69 101 (17) 203 (30) 304 (24)
70–80 9 (02) 48 (07) 57 (05)
>80 0 (00) 4 (01) 4 (<1)
Race a
Black/African American 148 (25.6) 70 (10.3) 218 (17.3)
Caucasian/White 405 (70.0) 588 (86.1) 993 (78.7)
Asian 3 (<1.0) 7 (01.0) 10 (<1.0)
Other 23 (04.0) 18 (02.6) 41 (03.3)
Ethnicity
Hispanicb 56 (09.7) 44 (06.4) 100 (07.9)
Smoking
Ever Smoked MACS Visit 1 to 24 months before HPV testing
Yes 427 (73.8) 486 (71.2) 913 (72.4)
No 152 (26.2) 197 (28.8) 349 (27.6)
Ever Smoked within last 24 months before HPV testing c
Yes 189 (32.6) 123 (18.0) 312 (24.7)
No 390 (67.4) 560 (82.0) 950 (75.3)
AIDS Defining Illnessesd
None 486 (83.9)
Kaposi’s Sarcoma 17 (02.9)
Pneumocystis Pneumonia 26 (04.5)
Non-Hodgkin’s Lymphoma 1 (00.2)
Wasting Syndrome 15 (02.6)
HPV-DNA Prevalence
None 54 (09.3) 203 (29.7) 257 (20.4)
1 HPV Type 525 (90.7) 480 (70.3) 1005 (79.6)
IARC HPV Carcinogenicity Classification
Group 1, strong carcinogens 396 (68) 306 (45) 702 (56)
Group 2, weaker carcinogens 255 (44) 186 (27) 441 (35)
Lower Risk 445 (77) 322 (47) 767 (61)
HPV 16 or 18 180 (31.1) 139 (20.4) 319 (25.3)
HPV 16 133 (23.0) 109 (15.9) 242 (19.2)
HPV 18 69 (11.9) 40 (05.9) 109 (08.6)
a

p<0.001, b p = 0.037, c p<0.001, dcategories are not mutually exclusive, e p = 0.062; f p = 0.138 g p<0.001. P-values for comparing HIV+ vs. HIV- were by the Fisher exact test or the Wilcoxon nonparametric test, as appropriate.